Cancer Science

Papers
(The H4-Index of Cancer Science is 39. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-10-01 to 2024-10-01.)
ArticleCitations
Reactive oxygen species in cancer: Current findings and future directions343
Pyroptosis, a new bridge to tumor immunity123
Icariin‐induced inhibition of SIRT6/NF‐κB triggers redox mediated apoptosis and enhances anti‐tumor immunity in triple‐negative breast cancer102
CAR‐NK cell in cancer immunotherapy; A promising frontier89
Real‐world data on microsatellite instability status in various unresectable or metastatic solid tumors85
Serum exosomal miR‐638 is a prognostic marker of HCC via downregulation of VE‐cadherin and ZO‐1 of endothelial cells83
CIRCULATE‐Japan: Circulating tumor DNA–guided adaptive platform trials to refine adjuvant therapy for colorectal cancer82
Interstitial pneumonitis related to trastuzumab deruxtecan, a human epidermal growth factor receptor 2‐targeting Ab–drug conjugate, in monkeys74
Ferroptosis‐related gene signature associates with immunity and predicts prognosis accurately in patients with osteosarcoma72
Tislelizumab in Asian patients with previously treated locally advanced or metastatic urothelial carcinoma70
The roles and regulation of the KLF5 transcription factor in cancers60
Clonal hematopoiesis and associated diseases: A review of recent findings57
Alectinib for relapsed or refractory anaplastic lymphoma kinase‐positive anaplastic large cell lymphoma: An open‐label phase II trial56
Gut‐liver axis‐mediated mechanism of liver cancer: A special focus on the role of gut microbiota55
Tumor‐homing peptide and its utility for advanced cancer medicine54
The gut microbiota associated with high‐Gleason prostate cancer54
Liposomal irinotecan (Onivyde): Exemplifying the benefits of nanotherapeutic drugs53
The noncanonical role of EZH2 in cancer51
Exosomal circGSE1 promotes immune escape of hepatocellular carcinoma by inducing the expansion of regulatory T cells51
Amino acid transporters as emerging therapeutic targets in cancer50
Risk stratification for the prognosis of patients with chemoresistant urothelial cancer treated with pembrolizumab49
Ferroptosis is induced by lenvatinib through fibroblast growth factor receptor‐4 inhibition in hepatocellular carcinoma48
IGF2BP2 promotes the progression of colorectal cancer through a YAP‐dependent mechanism48
H19 promotes aerobic glycolysis, proliferation, and immune escape of gastric cancer cells through the microRNA‐519d‐3p/lactate dehydrogenase A axis48
SHARPIN promotes cell proliferation of cholangiocarcinoma and inhibits ferroptosis via p53/SLC7A11/GPX4 signaling47
Establishment and implementation of Cancer Genomic Medicine in Japan45
Immune infiltration profiling in gastric cancer and their clinical implications45
Enhanced anti‐tumor effects of the PD‐1 blockade combined with a highly absorptive form of curcumin targeting STAT344
Low‐dose decitabine plus venetoclax is safe and effective as post‐transplant maintenance therapy for high‐risk acute myeloid leukemia and myelodysplastic syndrome43
Immunosuppressive activity is attenuated by Astragalus polysaccharides through remodeling the gut microenvironment in melanoma mice43
Proteomic analysis of urinary and tissue‐exudative extracellular vesicles to discover novel bladder cancer biomarkers42
Clinical characterization and immunosuppressive regulation of CD161 (KLRB1) in glioma through 916 samples42
PDL1‐positive exosomes suppress antitumor immunity by inducing tumor‐specific CD8+ T cell exhaustion during metastasis42
The heterogeneity of cancer‐associated fibroblast subpopulations: Their origins, biomarkers, and roles in the tumor microenvironment41
Real‐world data on NGS using the Oncomine DxTT for detecting genetic alterations in non‐small‐cell lung cancer: WJOG13019L41
Regulation of vascular permeability in cancer metastasis41
Long noncoding RNA just proximal to X‐inactive specific transcript facilitates aerobic glycolysis and temozolomide chemoresistance by promoting stability of PDK1 mRNA in an m6A‐dependent manner in gli40
Prognosis of patients with adult T‐cell leukemia/lymphoma in Japan: A nationwide hospital‐based study39
Concomitant overexpression of mir‐182‐5p and mir‐182‐3p raises the possibility of IL‐17–producing Treg formation in breast cancer by targeting CD3d, ITK, FOXO1, and NFATs: A meta‐analysis and experime39
Aptamer‐based biosensors and application in tumor theranostics39
0.037230968475342